Related Experiment Video
Updated: Nov 11, 2025

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3
Zhongbo Hu1, Kristen A VanHeyst1, Jignesh Dalal1
1Department of Pediatrics Division of Pediatric Hematology Oncology Rainbow Babies and Children's Hospital at University Hospitals Cleveland Medical Center Cleveland OH USA.
Abstract:
DS-ALL has a higher rate of relapse and treatment-related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis. Transient long-term remission after ALL relapse due to partial chemotherapy combined severe infection is rare.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018